chrisvoncsefalvay/vaers-outcomes huggingface dataset:
up all night with diarrhea; dry heaving; headache,splitting headache; chills; sick; felt tired,fatigue; brain fog; nausea; This is a spontaneous report from a contactable consumer (patient).    A 24-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EM9809), via an unspecified route of administration, in Arm Right on 10Feb2021 at 12:00 (at 24 years) at single dose for covid-19 immunisation. Medical history included seasonal allergy. Patient previously took Levaquin and had allergy. The patient previously took the first dose of the vaccine on 15Jan2021 at 10:00 am (at 24 years; lot EL9261) administered in right arm for covid-19 immunisation with no adverse event.Concomitant medications included probiotics, cetirizine hydrochloride (ZYRTEC), ergocalciferol (VIT D) and birth control pills (unspecified).  Patient received second dose of the vaccine on 10Feb2021 and she felt tired and sick on 11Feb2021 and on 12Feb2021. On 13Feb2021 night patient was up all night with diarrhea, dry heaving, chills and headache. On 14Feb2021 she was in bed all day. Every day since then (Feb2021) she had a horrible splitting headache, nausea, brain fog, fatigue and chills. She had not had a fever. Her doctor tested her for covid via Nasal swab on 17Feb2021 and she was negative. On 17Feb2021 she also ran comprehensive metabolic panel and other labs and they were normal. Her symptoms point towards an extreme and long reaction to the covid vaccine. Events required doctor or other healthcare professional office/clinic visit. Treatment included Prescription nausea medication. The final outcome of all the events was recovering.
First shingle shot around 11:30 a.m. By 9:30 feeling very flu-like. Whole body ached chills. Was unable to go to work the next day.
Moderna COVID-19 Vaccine EUA. Woken up at 5:45 am by a cluster of severe chills. Coming out of sleep I figured I had probabl started a fever. Went to ask my husband to get me ibuprofen and my speech was completely garbled. I do have recordings of my speech at that time. Lasted approx 2 hours.
UPON ADMINISTERING PFIER 2ND DOSE VACCINE TO PT IN L DELTOID, THE NEEDLE FELL OFF THE SYRINGE AND PT ONLY RECEIVED LESS THAN HALF THE DOSE. PT WAS RECD A REPEAT IN THE R DELTOID AS PER PROTOCOL.
flu; Initial information received on 05-Jan-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves Adult of unknown gender patient who experienced flu, while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (dose, formulation, lot number not reported via unknown route in unknown administration site) as prophylactic vaccination.  On an unknown date, the patient developed a non-serious event" flu" (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported"got the flu shot got the flu."  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
about 1hr p/vax SOB, dizzy, h/a, nausea-Ibuprofen & DPH given;24APR97 had tightness in chest, uncontrollable shaking & numbness arms, leg & back & terrible;h/a saw pvt MD;
Immediately after vaccine was given patient felt numbness in arm extending from where shot was given to hand. She said her arm was completely numb but had tingling in hand and fingers. Also complained of tightness in chest, shortness of breath. Patient was able to move hand and fingers. Said tightness in chest was like she felt when her back was out of place. Patient reported no swelling in throat. Observed & followed up with patient for 1 hour. Her tightness in chest improved but was still experiencing  numbness in arm and tingling in hand & fingers. She was following up with a medical facility.
subconjunctival hemorrhage 2 days after 2nd dose of Moderna vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of CONJUNCTIVAL HAEMORRHAGE (subconjunctival hemorrhage 2 days after 2nd dose of Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No medical history reported by the reporter.  Concomitant products included INSULIN, CICLOSPORIN (RESTASIS) and LATANOPROST for an unknown indication.   On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced CONJUNCTIVAL HAEMORRHAGE (subconjunctival hemorrhage 2 days after 2nd dose of Moderna vaccine) (seriousness criterion medically significant). The patient was treated with DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE (COSOPT PF) at a dose of UNK dosage form and Lumify eye drops at a dose of UNK dosage form. At the time of the report, CONJUNCTIVAL HAEMORRHAGE (subconjunctival hemorrhage 2 days after 2nd dose of Moderna vaccine) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Headache; body aches; tired; loss of taste; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 09Mar2021 14:30 (Batch/Lot number was not reported) (at the age of 53 years-old) as 2nd dose, single dose for covid-19 immunisation.  Medical history included thyroid, migraine, allergy, acid reflux. However, the patient also reported that her other medical history was "none". The patient was not pregnant. The patient did not have Covid prior to vaccination. The patient had no known allergies. Concomitant medications included medications for thyroid, migraine, allergy, acid reflux and an inhaler. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) in the left arm on 16Feb2021 at 02:30 PM (at the age of 53-years-old) for Covid-19 immunisation. The patient did not receive other vaccines in four weeks. The patient experienced headache, body aches, tired, loss of taste/lost sense of taste. All started 20 hrs after on 10Mar2021 at 10:30 AM. Loss of taste was still here 4 days later.  No treatment was received for the events. The patient was not tested for Covid post vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible, information about batch number cannot be obtained.
patient received first moderna vaccine and johnson and johnson vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received first moderna vaccine and johnson and johnson vaccine) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product COVID-19 VACCINE NRVV AD26 (JNJ 78436735) for an unknown indication.    No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, the patient started COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (unknown route) at an unspecified dose. On 06-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received first moderna vaccine and johnson and johnson vaccine). On 06-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received first moderna vaccine and johnson and johnson vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.
Dizziness, Headache, flushed, dry mouth, fatigue Narrative:  Emploee states: appox 40 minutes after receiving first vaccine dose she experienced side effects and had to leave work: drunk feeling, very dizzy, flushed, right-sided headache, dry mouth and extreme fatigue
An hour after receiving the pneumonia vaccine huge lumps 3-5 in in height appeared on my arm-lasted 6-7 days some pain.
The pt developed 5x3cm area on left deltoid presented with edema, min induration, tenderness, warmth and redness. Ice applied and observed. Augmentin given.
SEVERE PAIN IN ARM AND SHOULDER, COULDN'T MOVE ARM. PAIN LESSENED BUT DID NOT GO AWAY.  WENT TO DOCTOR IN DECEMBER, HAD XRAYS AND MRI. DIAGNOSIS- PERIPHERALLY DOWNSLOPING TYPE II ACROMIUM WITH KEEL-SHAPED SUBACROMIAL BONES SPURS, LIKELY RESULTING IN IMPINGEMENT, FRAYING AND PARTIAL TEARING OF THE SUPRASPINATUS AND INFRASPINATUS TENDONS, MODERATE SUBACROMION/SUBDELTOID BURSITIS.
Child had a fever of 105, he later looked and acted differently. Stopped talking, is currently non-verbal has loss a total of 50 words. In Sept 2006, he had more vaccines listed below and they worsen condition 100%.  7/31/2007 MR received from PCP beginning with NB check through 6/2007.  Normal growth and development noted until 4/5/2007 where delayed speech and loss of words noted. Assessment:  Delayed speech with regression. Addendum to sick visit 6/15/2007 "per mom"- decreased words (regressed from ~50), decreased play with other children, "spinning", and gross motor regression.
Expired vaccine used; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 006M20A and 003A21A) for COVID-19 vaccination.     The patient's past medical history included UTI, Emphysema, Cyst breast, Tobacco abuse (30 pack per year), Ovarian cancer, Lung cancer, Breast cancer, Cervical cancer, Osteoporosis, Skin cancer, Colon cancer, Colonic diverticulosis and Thyroidectomy. Previously administered products included for Product used for unknown indication: Influenza on 12-Sep-2018, Influenza on 20-Oct-2021, ADACEL and Pneumococcal vaccine. Past adverse reactions to the above products included No adverse event with ADACEL and Pneumococcal vaccine; and No adverse reaction with Influenza and Influenza. Family history included Breast cancer. Concurrent medical conditions included Impaired fasting glucose, Hypoparathyroidism, Hypocalcemia, Vitamin D deficiency, Temporomandibular joint disorder, Hypothyroidism, Hypertension, Hyperlipidemia and Penicillin allergy (MILD). Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]) from 04-Feb-2013 to an unknown date for Acid reflux (esophageal), ZOLPIDEM TARTRATE for Sleeplessness, ATENOLOL from 29-Nov-2021 to an unknown date, VITAMIN D3 from 04-Feb-2013 to an unknown date, ASCORBIC ACID, BIOFLAVONOIDS NOS, HESPERIDIN, MALPIGHIA GLABRA, ROSA CANINA, RUTOSIDE (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS;HESPERIDIN;MALPIGHIA GLABRA;ROSA CANINA;RUTOSIDE]), MULTIVITAMIN [ASCORBIC ACID;CALCIUM PANTOTHENATE;COLECALCIFEROL;CYANOCOBALAMIN;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE], CHROMIUM PICOLINATE, ALPHA LIPOIC ACID, CALCIUM, COLOSTRUM (METAGENICS PROBIOPLEX), ACETYLSALICYLIC ACID (ASPIRIN 81), HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ), LEVOTHYROXINE, ATORVASTATIN, MUPIROCIN and CEFALEXIN (CEPHALEXINE) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 10-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood thyroid stimulating hormone: abnormal abnormal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient has to take  FLUVAX,PNEUMOVAX , TD Booster vaccines. Patient has to check for BP DIASTOLIC,BP SYSTOLIC Treatment medications were not reported.   This case was linked to MOD-2021-424036 (Patient Link).
approx 5 seconds p/vax pt stated was feeling faint; @ which point lost consciousness for several seconds; ammonia inhalant was used to revive pt; BP 140/80, R20, P84;
Received vaccine on afternoon of 3/15/2021 and began experiencing nausea and vomiting, left arm and shoulder pain, fever, body aches, fatigue, and abdominal pain the morning of 3/16/20. He notified the pharmacy that administered the vaccine to him and they told him that some people have those symptoms with it. On 3/16/21 he went to bed around 11:30 PM feeling terrible and was found dead in his bed the next day (3/17/21) with dried blood coming out of his nose and mouth.
nurse administered Pfizer 0.3 ml undiluted vaccine dose, no symptoms after 30 minute observation time Attempted to contact mother on 10/27/2021 but no response to voicemail left but she did return call on 10/28/2021 and reports no complaints as of this time but would contact me with any symptoms. Mom reports to be a "nurse" and was advised of possible symptoms to observe/monitor for
fever; Chills; soreness; Achiness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achiness), PYREXIA (fever), CHILLS (Chills) and ARTHRALGIA (soreness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 038K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced PAIN (Achiness) and ARTHRALGIA (soreness). On 10-Feb-2021, the patient experienced PYREXIA (fever) and CHILLS (Chills). The patient was treated with IBUPROFEN for Fever, Chills and Ache, at a dose of 1 dosage form. On 14-Jan-2021, PAIN (Achiness) and ARTHRALGIA (soreness) had resolved. On 11-Feb-2021, PYREXIA (fever) and CHILLS (Chills) had resolved.            No concomitant medication were reported The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable
Redness, swelling and warm to touch at injection site. Low grade fever developed during the day and vomiting at night.
Headache for few hours; Redness on the injection site; Swelling on the injection site; This spontaneous case was reported by a physician and describes the occurrence of HEADACHE (Headache for few hours), VACCINATION SITE ERYTHEMA (Redness on the injection site) and VACCINATION SITE SWELLING (Swelling on the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache for few hours), VACCINATION SITE ERYTHEMA (Redness on the injection site) and VACCINATION SITE SWELLING (Swelling on the injection site). At the time of the report, HEADACHE (Headache for few hours), VACCINATION SITE ERYTHEMA (Redness on the injection site) and VACCINATION SITE SWELLING (Swelling on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications  were not reported  Treatment was not specified   This case was linked to US-MODERNATX, INC.-MOD-2021-008799, US-MODERNATX, INC.-MOD-2021-069012 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-008799: US-MODERNATX, INC.-MOD-2021-069012:dose 2
74y/o Caucasian woman, PMHx of Morbid Obesity, HTN, Hyperlipidemia, Hypothyroid, COPD who contracted COVID-19 in August 2021. She was hospitalized, treated and discharged home. Several months later, she received her 1st dose of Pfizer COVID Vaccine on 2/14/2022. A few hours later, developed epigastric and lower chest pain that lasted through the night. She came to Hospital Emergency Department on 2/15/2022. She was found to have Bilateral Pulmonary Emboli and was admitted to the hospital for further care and treatment.
Injection site ache & numbness, dry burning throat, trouble swallowing, coughing, burning eyes, fever, aches, fatigue.
12/01/04: Dry cough, fever; seen at Dr's office. Diagnosed with "bronchiotitis." No medication prescribed. Advised to use humidifier.  12/02/04: Synagis shot given at home by hospise nurse. This was a regular procedure since he was premature. 12/02/04: I called doctor's office to cancel "well baby" appointment, because he had just been seen the day before for a bad cough. I didn't think he should keep his appointment for his immunizations when he was this sick. The nurse said that if I didn't keep the appointment that we would be dropped as a patient and charged for a missed appointment. I said that typically with my other children, doctors don't want to give immunizations when the child is sick and tell me to reschedule well-baby appointments. I took him in because of her threats. He was seen by the doctor that day. I re-stated my concern about giving him immunizations when he was sick. He convinced me that it would be fine.  He was given four more shots that day (listed below) 12/03/2004: My husband and I were up early because he had an early day at work. (4 am) When I checked on him, he seemed to be sleeping in an odd position. When I went to adjust him, his head fell back and he was limp and not breathing. We called 911. While we waited for the ambulance, they told me to breathe softly into his mouth. I did with no response.  In the emergency room, they tried to revive him, but he died.
PARTIAL DOSE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced partial dose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of partial dose was not reported. This report was non-serious.
Site: Pain at Injection Site-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Hypotension-Medium, Additional Details: this patient has had similar events with all vaccines administered in the past. he has even had a similar event at work recently due to a cut on his hand.
Headache, Myalgia, Arthralgia & Fever Narrative: dose 2-day 1-2 fatigue; chills;fever; muscle ache; ha; fatigue
I had gone in for my yearly Mammogram and they found something. It was a second cluster of calcification which they had found first one about nine years ago. I had some more imaging done and then they did a biopsy. I ended up having surgery on 2/2 and 2/23 because it was cancerous I had an Invasive ductal carcinoma and Tis: Carcinoma in situ. I will have to have radiation and hormone therapy. I am still in pain and am waiting to see if I am going need chemotherapy as well.
Information has been received from a physician concerning a 57 year old female patient who on 15-APR-2008 was prescribed and vaccinated with a first dose of VARIVAX (Oka/Merck) (lot #658405/1076U) instead of ZOSTAVAX (Oka/Merck) on her left arm for shingles prevention. It was noted that no symptoms were reported. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Follow up information was received which reported that the medical assistance indicated that doctor inadvertently wrote VARIVAX (Oka/Merck) in the prescription instead of ZOSTAVAX (Oka/Merck) and the nurse gave the patient VARIVAX (Oka/Merck). The patient did not have any adverse experience and they refused to be vaccinated with ZOSTAVAX (Oka/Merck) now. No further information is requested.
Hard, red lump noted rt upper thigh yesterday 10 days after vaccines given. No fever. Non tender. Better today. Measures 4cm x 2cm.
Approximately 16-17 days after Moderna Booster Shot, started having random small, raised hives on neck, torso, arms and flank areas.  Areas are red, and itchy.  Itching and redness would last about 20-30 minutes and subside. Flareups of the hives and itching though out the day is common, in random areas. (typically torso, chest, flank and neck)  Ruled out any new detergents, lotions, changes with clothing or any other new possible allergen.  Areas would have increased irritatation by things such as warmth to the site or clothing rubbing on the areas.  However, would have intermittent itching with no predetermined precursor as well. (Scalp, behind ears)  Started taking an OTC Antihistamine the following day after hives continued. (Loratidine 10mg daily)  Hives are manageable, but still continue to "pop up" throughout the day, even with an Antihistamine on board.  Currently almost a month since received the Moderna Booster Shot.
BRUISE AT INJECTION SITE; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (BRUISE AT INJECTION SITE) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination and ADALIMUMAB (HUMIRA) for Rheumatoid arthritis and Plaque psoriasis.    No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced INJECTION SITE BRUISING (BRUISE AT INJECTION SITE). At the time of the report, INJECTION SITE BRUISING (BRUISE AT INJECTION SITE) had resolved.            No concomitant medication was reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Patient received Humira as Solution for injection in pre-filled pen.  No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.